Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Abbott describes synthesis and evaluation of novel erythromycin derivatives

Oct. 7, 1997

Abbott prepares and evaluates tetracyclic ketolides as antibacterials

Oct. 6, 1997

New antifungal antibiotic with sphingosine-like lipid moiety

Oct. 6, 1997

Korean research institute synthesizes potent DNA gyrase inhibitors

Oct. 6, 1997

Taisho reports new macrolides termed "acylides"

Oct. 6, 1997

Novel class III antiarrhythmic agents described by Merck & Co.

Oct. 6, 1997

Korean researchers present novel 3-isoxazolylvinylcephalosporins

Oct. 3, 1997

R.W. Johnson identifies TCS inhibitor with potent antibacterial activity

Oct. 3, 1997

Microcide identifies cephalosporin with excellent Gram-positive activity

Oct. 3, 1997

Novel antibacterial agents that inhibit bacterial two-component systems

Oct. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...